Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,069 | 392 | 98.5% |
| Education | $99.35 | 3 | 1.2% |
| Consulting Fee | $24.68 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,766 | 138 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $897.33 | 43 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $895.09 | 46 | $0 (2024) |
| Janssen Biotech, Inc. | $511.70 | 29 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $484.26 | 4 | $0 (2020) |
| Gilead Sciences, Inc. | $280.68 | 10 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $266.31 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $250.77 | 14 | $0 (2024) |
| Allergan, Inc. | $247.64 | 16 | $0 (2020) |
| Intercept Pharmaceuticals, Inc. | $151.47 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,098 | 49 | Regeneron Healthcare Solutions, Inc. ($202.46) |
| 2023 | $1,202 | 46 | ABBVIE INC. ($593.33) |
| 2022 | $961.12 | 53 | ABBVIE INC. ($459.33) |
| 2021 | $960.07 | 51 | AbbVie Inc. ($473.21) |
| 2020 | $990.95 | 51 | AbbVie Inc. ($340.10) |
| 2019 | $1,272 | 51 | AbbVie, Inc. ($370.99) |
| 2018 | $980.41 | 52 | AbbVie, Inc. ($219.70) |
| 2017 | $728.35 | 43 | AbbVie, Inc. ($215.07) |
All Payment Transactions
396 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: VIROLOGY | ||||||
| 10/27/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: LIVER DISEASE | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Gastroenterology | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Gastroenterology | ||||||
| 10/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: VIROLOGY | ||||||
| 10/14/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Immunology | ||||||
| 10/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Gastroenterology | ||||||
| 09/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.98 | General |
| Category: Immunology | ||||||
| 09/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Immunology | ||||||
| 08/26/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: Immunology | ||||||
| 08/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Immunology | ||||||
| 08/09/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/05/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 07/22/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: INFLIXIMAB | ||||||
| 07/16/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $28.94 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/16/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/01/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 221 | 271 | $128,616 | $24,425 |
| 2022 | 8 | 260 | 311 | $142,967 | $28,762 |
| 2021 | 11 | 500 | 573 | $278,419 | $51,758 |
| 2020 | 11 | 437 | 541 | $235,893 | $47,992 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 28 | 30 | $28,290 | $6,016 | 21.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 65 | $13,650 | $4,042 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 37 | $14,504 | $2,939 | 20.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 32 | 33 | $19,800 | $2,792 | 14.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $11,661 | $2,756 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 34 | $9,321 | $2,063 | 22.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $7,600 | $1,944 | 25.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 28 | 30 | $23,790 | $1,873 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 62 | $24,304 | $5,502 | 22.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $19,266 | $4,315 | 22.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 33 | 35 | $27,755 | $3,717 | 13.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 18 | 18 | $16,974 | $3,620 | 21.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 36 | 36 | $21,600 | $3,315 | 15.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 58 | $12,180 | $3,263 | 26.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 26 | $10,400 | $2,775 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 38 | $10,488 | $2,256 | 21.5% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 50 | 50 | $47,150 | $10,244 | 21.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 82 | 104 | $37,570 | $8,722 | 23.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 64 | 108 | $22,680 | $6,223 | 27.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 58 | 58 | $28,785 | $6,138 | 21.3% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 66 | 66 | $52,338 | $5,510 | 10.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 50 | 50 | $20,000 | $5,426 | 27.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 63 | 65 | $39,000 | $5,073 | 13.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 31 | $7,926 | $2,077 | 26.2% |
| 43249 | Balloon dilation of esophagus, stomach and upper small bowel using a flexible endoscope | Facility | 2021 | 11 | 11 | $15,499 | $1,257 | 8.1% |
About Dr. Paresh Kamat, MD
Dr. Paresh Kamat, MD is a Gastroenterology healthcare provider based in Decatur, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/03/2009. The National Provider Identifier (NPI) number assigned to this provider is 1740518612.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paresh Kamat, MD has received a total of $8,193 in payments from pharmaceutical and medical device companies, with $1,098 received in 2024. These payments were reported across 396 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($8,069).
As a Medicare-enrolled provider, Kamat has provided services to 1,418 Medicare beneficiaries, totaling 1,696 services with total Medicare billing of $152,938. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Decatur, GA
- Active Since 12/03/2009
- Last Updated 05/19/2014
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740518612
Products in Payments
- XIFAXAN (Drug) $772.45
- STELARA (Biological) $763.95
- Humira (Biological) $536.73
- LINZESS (Drug) $415.45
- ENTYVIO (Biological) $400.64
- SKYRIZI (Biological) $396.22
- HUMIRA (Biological) $334.96
- DUPIXENT (Biological) $302.29
- RINVOQ (Biological) $273.23
- Entyvio (Biological) $238.07
- CREON (Drug) $221.01
- DIFICID (Drug) $213.67
- ZENPEP (Drug) $192.28
- MAVYRET (Drug) $191.56
- REMICADE (Biological) $186.18
- VIBERZI (Drug) $182.10
- GATTEX (Drug) $159.50
- Epclusa (Drug) $154.20
- Creon (Drug) $141.06
- Trulance (Drug) $128.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Decatur
Dr. Shirley Harris, M.d, M.D
Gastroenterology — Payments: $14,948
Muhammad Asim, Md, MD
Gastroenterology — Payments: $14,649
Dr. Kavitha Gopal, M.d, M.D
Gastroenterology — Payments: $10,819
Dr. Eric High, M.d, M.D
Gastroenterology — Payments: $10,351
Andrew Simpson, Md, MD
Gastroenterology — Payments: $10,335
Mark Stern, M.d, M.D
Gastroenterology — Payments: $9,677